Citadel Advisors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Hold
0
6784
2023
Q2
Hold
0
6746
2023
Q1
Sell
-203,159
Closed -$380K 6857
2022
Q4
$380K Buy
203,159
+161,276
+385% +$302K ﹤0.01% 4125
2022
Q3
$108K Sell
41,883
-57,979
-58% -$150K ﹤0.01% 5079
2022
Q2
$193K Sell
99,862
-11,160
-10% -$21.6K ﹤0.01% 5013
2022
Q1
$330K Sell
111,022
-58,626
-35% -$174K ﹤0.01% 4847
2021
Q4
$762K Buy
169,648
+142,209
+518% +$639K ﹤0.01% 4140
2021
Q3
$133K Sell
27,439
-16
-0.1% -$78 ﹤0.01% 5673
2021
Q2
$187K Buy
+27,455
New +$187K ﹤0.01% 5622
2021
Q1
Sell
-48,540
Closed -$303K 6968
2020
Q4
$303K Buy
+48,540
New +$303K ﹤0.01% 4228
2020
Q3
Sell
-35,672
Closed -$186K 5452
2020
Q2
$186K Buy
35,672
+6,882
+24% +$35.9K ﹤0.01% 4092
2020
Q1
$91K Sell
28,790
-54,984
-66% -$174K ﹤0.01% 4386
2019
Q4
$338K Buy
83,774
+560
+0.7% +$2.26K ﹤0.01% 3789
2019
Q3
$360K Sell
83,214
-31,036
-27% -$134K ﹤0.01% 3717
2019
Q2
$456K Buy
114,250
+7,639
+7% +$30.5K ﹤0.01% 3608
2019
Q1
$572K Sell
106,611
-5,652
-5% -$30.3K ﹤0.01% 3283
2018
Q4
$576K Buy
112,263
+59,171
+111% +$304K ﹤0.01% 3188
2018
Q3
$515K Sell
53,092
-226,971
-81% -$2.2M ﹤0.01% 3144
2018
Q2
$2.86M Buy
280,063
+129,212
+86% +$1.32M ﹤0.01% 1868
2018
Q1
$1.96M Buy
150,851
+118,679
+369% +$1.54M ﹤0.01% 1956
2017
Q4
$576K Sell
32,172
-61,505
-66% -$1.1M ﹤0.01% 2727
2017
Q3
$2.35M Buy
93,677
+38,716
+70% +$972K ﹤0.01% 1751
2017
Q2
$1.33M Sell
54,961
-50,889
-48% -$1.23M ﹤0.01% 1973
2017
Q1
$2.04M Buy
105,850
+94,610
+842% +$1.82M ﹤0.01% 1671
2016
Q4
$173K Buy
+11,240
New +$173K ﹤0.01% 3119
2015
Q3
Sell
-3,319
Closed -$86K 4371
2015
Q2
$86K Buy
+3,319
New +$86K ﹤0.01% 3309